Subcutaneous Drug Delivery Devices: A Leading Driver Behind Rising Prevalence Of Diabetes And Cardiovascular Diseases Boosts Growth In Subcutaneous Drug Delivery Device Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
What Will the Subcutaneous Drug Delivery Devices Industry Market Size Be by 2025?_x000D_
There has been a substantial expansion in the market size of subcutaneous drug delivery devices in the previous years. Estimates project an increase from $27.66 billion in 2024 to $29.77 billion in 2025, signifying a compound annual growth rate (CAGR) of 7.6%. Factors that contributed to this historical growth include a heightened occurrence of chronic illnesses, a surging demand for self-administered medication, escalating rates of diabetes and obesity, a patient preference for accessible therapies, and an increasing older population._x000D_
_x000D_
What's the Long-Term Growth Forecast for the Subcutaneous Drug Delivery Devices Market Size Through 2029?_x000D_
Expectations indicate that the market size of subcutaneous drug delivery devices will experience robust growth in the forthcoming years. The projections suggest the market will escalate to $39.57 billion in 2029, with a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in this period can be linked to the expansion of the biologics and biosimilars market, increased use of wearable drug delivery systems, broader acceptance of personalized medicine, enhancements in healthcare reimbursement policies, and an increased focus on home healthcare. Noteworthy trends during the forecast period include the amalgamation of digital health technologies, the creation of smart, interconnected devices, the proliferation of minimally invasive procedures, advancements in needle-free injection technology, and the introduction of artificial intelligence in device development._x000D_
_x000D_
View the full report here:_x000D_
https://www.thebusinessresearchcompany.com/report/subcutaneous-drug-delivery-devices-global-market-report_x000D_
_x000D_
What Are the Key Growth Drivers Fueling the Subcutaneous Drug Delivery Devices Market Expansion?_x000D_
An escalating occurrence of diabetes and cardiovascular diseases (CVD) is projected to fuel the expansion of the subcutaneous drug delivery devices market in future years. This rise is due to aging populations, unhealthy diet habits, physical inactivity, overweight conditions, social and economic disparities, stress, environmental influences, and inadequate access to preventative healthcare. Subcutaneous drug delivery devices are utilized for diabetes in delivering insulin and other medications for blood sugar regulation, and in cardiovascular disorders for supplying medications such as anticoagulants or substances that decrease lipids, presenting a practical and regulated way of managing these long-term illnesses. For instance, according to the British Diabetic Association in April 2023, the latest statistics reveal that 4.3 million inhabitants of the UK are currently diagnosed with diabetes. The tally of registered cases for 2021-22 escalated by 148,951 compared to 2020-21, with over 2.4 million people being at a high risk of acquiring type 2 diabetes in the UK. Correspondingly, in May 2024 as per the reports of the Centers for Disease Control and Prevention, a US-based governmental organization, heart disease was accountable for the death of 702,880 individuals in 2022, representing 1 in every 5 fatalities. Therefore, the escalating prevalence of diabetes and cardiovascular diseases (CVD) is promoting the growth of the subcutaneous drug delivery devices market._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp_x000D_
_x000D_
What Are the Key Trends Driving Subcutaneous Drug Delivery Devices Market Growth?_x000D_
Leading businesses in the subcutaneous drug delivery devices market are prioritizing the creation of cutting-edge products like miniature digital liquid flow sensors. These devices aim to boost the safety and accuracy of subcutaneous drug delivery through the provision of precise, tailor-made flow sensors for high-volume injectables. Miniature digital liquid flow sensors, compact in nature, provide exact measurement of liquid flow rates in small-scale applications while providing a digital output for efficient monitoring and control. For example, Sensirion AG, a flow and environmental sensor provider based in Switzerland, introduced the SLD3x series sensor platform in May 2024. This suite of sensors comprises of highly accurate digital liquid flow sensors, which have customizable solutions, offering exact flow measurement. They also provide occlusion detection, in-line air bubble identification, and liquid temperature monitoring capabilities. These tiny sensors are perfect for use in large-scale medical device production, guaranteeing ideal dosing and improved patient safety during subcutaneous drug delivery._x000D_
_x000D_
How Is the Subcutaneous Drug Delivery Devices Market Segmented?_x000D_
The subcutaneous drug delivery devicesmarket covered in this report is segmented -_x000D_
_x000D_
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps_x000D_
2) By Application: Diabetes, Fertility, Oncology_x000D_
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers_x000D_
_x000D_
Subsegments:_x000D_
1) Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens_x000D_
2) Pen Needles: Standard Pen Needles, Safety Pen Needles_x000D_
3) Injector Pens: Disposable Injector Pens, Reusable Injector Pens_x000D_
4) Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors_x000D_
5) Implantable Pumps: Insulin Pumps, Drug Infusion Pumps_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=19723&type=smp_x000D_
_x000D_
Which Companies Are Leading the Charge in Subcutaneous Drug Delivery Devices Market Innovation?_x000D_
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd. _x000D_
_x000D_
Which Regions Are Leading the Global Subcutaneous Drug Delivery Devices Market in Revenue?_x000D_
North America was the largest region in the subcutaneous drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19723_x000D_
_x000D_
This Report Supports:_x000D_
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work._x000D_
_x000D_

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.